SCHEMBL1209641

SCHEMBL1209641

Cc1oncc1CNC(=O)OC1CCc2c(sc(NC(=O)CC(C)c3cccnc3)c2C#N)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.40
KDM4E B2RXH2 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
HPGD P15428 3/20 0.40
RAB9A P51151 3/20 0.40
HTT P42858 2/20 0.40
HSD17B10 Q99714 2/20 0.40
NPC1 O15118 2/20 0.40
MAPT P10636 10/20 0.39
LMNA P02545 2/20 0.39
GAA P10253 2/20 0.39
MEN1 O00255 4/20 0.38
POLB P06746 4/20 0.38
KMT2A Q03164 4/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
ESR1 P03372 1/20 0.37
OPRK1 P41145 1/20 0.37
ESR2 Q92731 1/20 0.37
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1209025 0.93 ALDH1A1 (0.44) ALDH1A1KDM4ESMN1; SMN2HPGDRAB9A
SCHEMBL12895477 0.90 KDM4E (0.35) ALDH1A1KDM4ERAB9AMAPTPOLB
SCHEMBL1208260 0.89 ALDH1A1 (0.39) ALDH1A1KDM4ESMN1; SMN2HPGDRAB9A
SCHEMBL1208704 0.87 MAPT (0.38) ALDH1A1KDM4ESMN1; SMN2HPGDRAB9A
SCHEMBL1208761 0.85 L3MBTL1 (0.49) ALDH1A1KDM4ESMN1; SMN2HPGDRAB9A
SCHEMBL1209722 0.85 MAPT (0.46) ALDH1A1KDM4ESMN1; SMN2HPGDRAB9A
SCHEMBL1207619 0.84 ALDH1A1 (0.41) ALDH1A1KDM4ESMN1; SMN2HPGDRAB9A
SCHEMBL12882703 0.84 ALDH1A1 (0.41) ALDH1A1KDM4ESMN1; SMN2HPGDRAB9A
SCHEMBL14293234 0.83 HPGD (0.36) ALDH1A1KDM4ESMN1; SMN2HPGDRAB9A
SCHEMBL1209532 0.82 ALDH1A1 (0.42) ALDH1A1KDM4ESMN1; SMN2HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES NYCOMED GMBH (DE) 2011-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES BAX, BCL2, BAD ALDH1A1 316/4885KDM4E 2054/4885SMN1; SMN2 2135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.